Dr. Lewis on New and Emerging Treatments for Melanoma

Video

Karl Lewis, MD, medical oncologist, associate professor, University of Colorado, discusses new and emerging treatments for metastatic melanoma

Karl Lewis, MD, medical oncologist, associate professor, University of Colorado, discusses new and emerging treatments for metastatic melanoma.

Lewis says the list of new and emerging treatments for metastatic melanoma has grown due to the tremendous advancements in the field over the last couple of years.

In the immunotherapy field, Lewis says, ipilimumab showed a survival advantage for the first time in patients with melanoma. Progress is also being made with the development of PD-1 antibodies and PD-1 ligand antibodies.

There have also been developments in molecular targeted therapies, Lewis say, including agents targeting the RAS/RAF pathway, BRAF inhibitors, and MEK inhibitors.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD